According to our team’s present results, it seems that MMP-7 may be considered in the future as a modern BC marker, including Luminal A and Luminal B HER2-negative subtypes, as a single parameter or in a combined analysis with CA 15-3. Here, ERBB2 is linked to breast cancer.